157979-33-4

Upstream product

• 1309077-07-3 5-(tert-butyldiphenylsilanyloxymethyl)pyrrolidin-2-one 
• 62400-75-3 pyroglutamol 
• 58479-61-1 tert-butylchlorodiphenylsilane 

Downstream Products

• 157979-35-6 2-(tert-butyldiphenylsilanyloxymethyl)-5-methoxypyrrolidine-1-carboxylic acid tertbutyl ester 
• 1309077-13-1 3-(tert-butyldiphenylsilanyloxymethyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester 
• 1309077-14-2 3-hydroxymethyl-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester 
• 1313816-85-1 t-butyl 3-[N-(benzyloxycarbonyl)-N-(methyl)aminomethyl]-2-azabicyclo[3.1.0]hexane-2-carboxylate 

Relevant academic research and scientific papers

BICYCLIC COMPOUNDS AS alpha4 beta2 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS

The present invention relates to novel bicyclic compounds of the formula (I), and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing t

Alpha 4 Beta 2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS

The present invention relates to novel α4β2 neuronal nicotinic acetylcholine receptor ligand compounds of the formula (I), and their derivatives, stereoisomers, pharmaceutically acceptable salts and compositions containing them. The

BICYCLIC COMPOUNDS AS α4β2 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS

The present invention relates to novel bicyclic compounds of the formula (I), and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing t

α4β2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS

The present invention relates to novel α4β2 neuronal nicotinic acetylcholine receptor ligand compounds of the formula (I), and their derivatives, stereoisomers, pharmaceutically acceptable salts and compositions containing them. The